PROVIDER PROFILE · NPI 1912016676

Eric TreiberMD

PRACTICERUTH KAPLAN TREIBER, MD & ERIC S. TREIBER, MDSee all providers at this practice →

DermatologyRye, NYI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

1,542

Unique beneficiaries

—

Total services

2,802

Distinct HCPCS

Medicare payment

$156K

Peer benchmark

Total Medicare services vs. 960 Dermatology providers in NY — above median (cohort median 1,575).

PRESCRIBING · PART D · 2024

Total Rx claims

848

Beneficiaries

—

Total drug cost

$247K

Distinct drugs

Brand share

15.7%

Top prescribed drugs

Triamcinolone Acetonide128 claims

Mupirocin117 claims

Hydrocortisone84 claims

Ketoconazole82 claims

Ciclopirox Olamine41 claims

QUALITY · MIPS · 2024

Final MIPS score

100.0

Quality

100.0

Cost

0.0

Improvement activities

40.0

Promoting interop.

100.0

Payment adjustment

1.05%

Group

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$121

Payment records

By payment type

Food and Beverage$121

REFERRAL NETWORK

Where Eric Treiber's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 5 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
HORST, BASIL	58	84
WHITE PLAINS HOSPITAL MEDICAL CENTER	34	102
David Silvers Pathology · New York, NY	31	43
THE NEW YORK AND PRESBYTERIAN HOSPITAL	22	39
Laboratory Corporation Of America Holdings Clinical Laboratory · Raritan, NJ	11	18

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history